Sweden’s Public Health Agency recommended suspending administration of the Novavax COVID-19 vaccine to individuals aged 30 years old and younger this week.
The agency said Wednesday it was a temporary measure due to concerns about the vaccine increasing risk of heart inflammation. Authorities will wait until more data is available on the risk of developing pericarditis or myocarditis from the shot before making a final decision.
No comments:
Post a Comment